Technology News and Research

RSS

Mobile apps can help promote physical activity during COVID-19 lockdown

Gyms and sporting clubs might close, and lockdown conditions make it difficult to exercise, but people are urged to take the next step and download fitness apps to keep moving.

5 Aug 2021

RIZE’s XRIZE Full-Color Printer Now Compatible with Synopsys Simpleware for 3D Medical Printing

RIZE, Inc. today announced that its XRIZE® 3D printing platform is compatible with Synopsys’ FDA 510(k)-cleared Simpleware™ software.

From Synopsys Simpleware™ Software 5 Aug 2021

Medical associations join forces to remove regulatory barriers to noninvasive ventilation

On July 30, 2021, the journal CHEST® electronically published the outcomes and recommendations of a technical expert panel on optimal noninvasive ventilation, conducted by the American College of Chest Physicians, the American Academy of Sleep Medicine, the American Association for Respiratory Care, and the American Thoracic Society.

4 Aug 2021

FDA announces participation in new collaborative communities to tackle medical device challenges

Today, the U.S. Food and Drug Administration announced participation in several new collaborative communities aimed at addressing challenges in patient health care.

4 Aug 2021

New LSHTM spin-out company aims to improve detection and control of infectious diseases

Two spin-out companies from the London School of Hygiene & Tropical Medicine (LSHTM) have merged to form a new company that will improve the detection and control of infectious diseases.

4 Aug 2021

Drug-eluting endotracheal tubes for preventing airway complications

In a proof-of-concept study, researchers at Children's Hospital of Philadelphia have created a coating that can be applied to endotracheal tubes and release antimicrobial peptides that target infectious bacteria with specificity.

4 Aug 2021

Artificial pancreas may soon help patients with type 2 diabetes

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis. Tests led by the University of Cambridge and Inselspital, University Hospital of Bern, Switzerland, show that the device can help patients safely and effectively manage their blood sugar levels and reduce the risk of low blood sugar levels.

4 Aug 2021

Common weight-loss drug successfully targets fat in adults with obesity at high cardiovascular risk

Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide.

4 Aug 2021

Scientists identify new therapeutic target for several aggressive cancers

A protein in tumor cells could be targeted to treat some types of aggressive cancer including brain, blood, skin, and kidney, new research has shown.

4 Aug 2021

LEDs can help inactivate SARS-CoV-2 virus

LEDs are commonly used for sterilization -- you may be using one to clean your electric toothbrush, for example. In the continued effort to combat the coronavirus pandemic, LEDs can also help inactivate SARS-CoV-2.

4 Aug 2021

Cardiac pacemaker could be powered by kinetic energy from the heart

The cardiac pacemaker of the future could be powered by the heart itself, according to researchers at Shanghai Jiao Tong University.

4 Aug 2021

Investigational treatment improves survival rate of babies lacking thymus

An investigational treatment pioneered by a Duke Health pediatrician resulted in a one-year survival rate of 77% among children born with a rare condition in which they lack an immune system.

4 Aug 2021

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Rigaku Corporation (Headquarters: Akishima-shi, Tokyo; President: Toshiyuki Ikeda; "Rigaku"), a leading manufacturer of X-ray analysis equipment, has acquired all issued shares of MILabs B.V. (Headquarters: Houten, The Netherlands; CEO and CSO: Dr. Frederik Beekman; “MILabs”)

From Rigaku Corporation 4 Aug 2021

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

The University of Oxford's and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca's joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

4 Aug 2021